Develops medicines for neurodegenerative diseases crossing the blood-brain barrier.
| Title |
|---|
| Vice President, Intellectual Property (IP) - Hybrid Full Time · $311K-$419K · 20+ YOE South San Francisco, California, United States · Hybrid |
| Vice President, Quality Full Time · $328K-$366K · 20+ YOE South San Francisco, California, United States · Onsite |
| Manager, Biosample Operations Full Time · $139K-$201K · 5+ YOE South San Francisco, California, United States · Onsite |
| Senior Process Engineer Full Time · 8+ YOE Salt Lake City, Utah, United States · Onsite |
| Associate Director, Clinical Quality Full Time · $194K-$224K · 7+ YOE South San Francisco, California, United States · Onsite |
| Senior Director, Medical Information Full Time · $248K-$277K · 12+ YOE South San Francisco, California, United States · Onsite |
| Senior Manager, QC Microbiology Full Time · 8+ YOE Salt Lake City, Utah, United States · Onsite |
| Director, Regulatory & Medical Writing Full Time · $211K-$259K · 10+ YOE South San Francisco, California, United States · Onsite |
| Associate Director, QC Chemistry Full Time · 7+ YOE Salt Lake City, Utah, United States · Onsite |
| Senior Automation Engineer Full Time · 3+ YOE Salt Lake City, Utah, United States · Onsite |
| Quality Engineer Full Time · 5+ YOE Salt Lake City, Utah, United States · Onsite |
| Associate Director, MSAT Late Stage Full Time · 7+ YOE Salt Lake City, Utah, United States · Onsite |
| Senior Manager, Clinical Supply Chain Full Time · $152K-$185K · 5+ YOE South San Francisco, California, United States · Onsite |
| Activities | Drug discoveryClinical developmentBiopharmaceutical researchNeurodegenerative therapy developmentBlood-brain barrier technology |
| Headquarters | US |
| Industries | BiotechnologyPharmaceuticals |
| Name | Denali Therapeutics |
| Employees | 503 |
| Type | Public |
| Subsidiaries | Denali BBB Holding LimitedDenali Therapeutics International GmbH |
| Tagline | Develops medicines for neurodegenerative diseases crossing the blood-brain barrier. |
| Founded | 2,015 |
| Website | denalitherapeutics.com |
| Stock Exchange | NASDAQ |
| Stock Symbol | DNLI |